Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

6.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thrombocytopenia in carriers and patients with antiphospholipid syndrome: insights from the nationwide START-APS registry.

Internal and emergency medicine·2026
Same author

Perioperative Treatment of a Patient With Combined Factor IX and XI Deficiency Undergoing Cholecystectomy: A Case Report and Brief Literature Review.

American journal of therapeutics·2026
Same author

Drug Interactions Between Direct Oral Anticoagulants and Nonsteroidal Anti-inflammatory Drugs: A Clinical Risk-Benefit Analysis With Focus on Special Populations.

American journal of therapeutics·2026
Same author

Are the Direct Oral Anticoagulants Better Than Warfarin for the Prevention and Treatment of Stroke and Atrial Fibrillation?

Handbook of experimental pharmacology·2026
Same author

Anti-Xa-Guided Heparin Therapy in a Pregnant Woman With a Mechanical Heart Valve.

American journal of therapeutics·2025
Same author

Case Report: Thrombocytopenia Induced by Intravenous Ferrous Carboxymaltose.

American journal of therapeutics·2025

Related Experiment Video

Updated: Jul 29, 2025

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

6.9K

Performance and Interpretation of Clot Waveform Analysis.

Maria Filomena Ruberto1, Francesco Marongiu2, Doris Barcellona2,3

  • 1Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy. rubertofilomena@tiscali.it.

Methods in Molecular Biology (Clifton, N.J.)
|May 19, 2023
PubMed
Summary

Clot waveform analysis (CWA) enhances routine coagulation tests like prothrombin time (PT) and activated partial thromboplastin time (aPTT). CWA provides dynamic clot formation insights, aiding diagnosis in various bleeding and clotting disorders.

Keywords:
Clot waveform analysisCoagulationFirst and second derivativesPTaPTT

More Related Videos

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
06:16

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Published on: April 19, 2024

1.0K
An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

2.8K

Related Experiment Videos

Last Updated: Jul 29, 2025

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

6.9K
Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
06:16

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Published on: April 19, 2024

1.0K
An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

2.8K

Area of Science:

  • Hematology
  • Clinical Chemistry
  • Biomedical Engineering

Background:

  • Prothrombin time (PT) and activated partial thromboplastin time (aPTT) are standard coagulation screening tests.
  • These tests detect hemorrhagic defects but are limited in identifying hypercoagulable states.
  • Clot waveform analysis (CWA) offers a dynamic approach to studying clot formation.

Purpose of the Study:

  • To present the materials and methods for detecting additional clotting parameters using CWA.
  • To expand the utility of PT and aPTT beyond basic screening.
  • To provide deeper insights into both hypocoagulable and hypercoagulable states.

Main Methods:

  • Utilizing clot waveform analysis (CWA) with dedicated algorithms in a coagulometer.
  • Analyzing the velocity, acceleration, and density of clot formation from PT and aPTT measurements.
  • Implementing specific algorithms to detect the entire clot formation process from fibrin polymerization.

Main Results:

  • CWA provides quantitative data on clot formation dynamics (velocity, acceleration, density).
  • These parameters offer valuable information for diagnosing and managing various coagulation disorders.
  • CWA has been applied to diverse conditions including hemophilia, DIC, sepsis, and liver cirrhosis.

Conclusions:

  • CWA significantly enhances the diagnostic capabilities of standard PT and aPTT tests.
  • This method provides crucial information for assessing both bleeding and thrombotic risks.
  • The presented methods enable a more comprehensive evaluation of coagulation dynamics.